regeneron_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
| Date of
Report (Date of earliest event reported): April 29,
2010 |
| REGENERON PHARMACEUTICALS,
INC. |
| (Exact Name of Registrant as Specified in
Charter) |
| New York |
|
000-19034 |
|
13-3444607 |
| (State or other jurisdiction of |
|
(Commission File No.) |
|
(IRS Employer Identification No.) |
| Incorporation) |
|
|
|
|
| 777 Old Saw Mill River Road, Tarrytown, New
York 10591-6707 |
| (Address of principal executive offices,
including zip code) |
| |
| (914)
347-7000 |
| (Registrant's
telephone number, including area code)
|
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following
provisions:
| c |
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
|
|
|
|
| c |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
|
|
|
|
| c |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
| c |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On April 29, 2010, Regeneron Pharmaceuticals, Inc. issued a press release
announcing its financial and operating results for the quarter ended March 31,
2010. The press release is being furnished to the Securities and Exchange
Commission pursuant to Item 2.02 of Form 8-K and is attached as Exhibit 99.1 to
this Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated April 29, 2010.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
| Date: April 29, 2010 |
REGENERON PHARMACEUTICALS,
INC. |
| |
| |
| |
By: |
/s/ Stuart
Kolinski |
| |
|
Name: |
Stuart Kolinski |
| |
|
Title: |
Senior Vice President and General
Counsel |
Exhibit
Index
| Number |
|
Description |
|
| 99.1 |
|
Press Release dated April 29,
2010. |